Research Studies

The study is looking for 200 adults diagnosed with T2D within the last 12 months. CU will enroll 100 of those participants. Participants will be assigned to one of two groups. The first group will receive individualized routine care. The second group will receive individualized routine care paired with the glucose excursion minimization guide and program. All participants will receive standard glycemic treatment management from their primary care doctor. There are three in-person visits for this study. Participants will receive some blood work at the beginning, and at both 4.5 months and 13.5 months later. Tests include clinical (hemoglobin A1c, lipids, blood pressure, weight, risk of cardiovascular disease, medication evaluation), behavioral (physical activity, carbohydrate intake) and psychosocial (depression, empowerment, diabetes distress) outcomes. Throughout the 13.5 month study period, each participant’s diabetes-related symptoms will be tracked.

Duration of Participation: 13.5 months